PROGENICS PHARMACEUTICALS INC 4
4 · PROGENICS PHARMACEUTICALS INC · Filed Nov 21, 2014
Insider Transaction Report
Form 4
ISRAEL ROBERT J
Sr. VP, Medical Affairs
Transactions
- Exercise/Conversion
Common Stock
2014-11-21$5.35/sh+9,000$48,150→ 44,050 total - Sale
Common Stock
2014-11-21$7.00/sh−9,000$63,000→ 35,050 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2014-11-21$7.00/sh−9,000$63,000→ 21,000 totalExercise: $5.35From: 2011-07-01Exp: 2020-07-01→ Common Stock (9,000 underlying)
Footnotes (2)
- [F1]The Reporting Person is exercising options under this grant in pre-established increments under and in accordance with provisions of a previously established Plan of Sale under Rule 10b5-1, which was established in accordance with the policies and procedures of the Issuer.
- [F2]The stock options become exercisable in three equal annual installments, commencing one year from the grant date.